Corticosteroid Injection Versus Tendon Dry Needling for Subacromial Impingement Syndrome
NCT ID: NCT05882786
Last Updated: 2023-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2023-07-01
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The corticosteroid (Triamcinolone Acetonide) injection group
Participants in this group will receive a single subacromial injection of 40mg triamcinolone acetonide.
Corticosteroid injection
Subacromial injection of 40mg triamcinolone acetonide.
Tendon dry needling group
Participants in this group will receive a total of 3 sessions of dry needling treatment to the supraspinatus, infraspinatus, and subscapularis muscle tendons.
Dry Needling
Dry needling treatment to the supraspinatus, infraspinatus, and subscapularis muscles tendons.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Corticosteroid injection
Subacromial injection of 40mg triamcinolone acetonide.
Dry Needling
Dry needling treatment to the supraspinatus, infraspinatus, and subscapularis muscles tendons.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of subacromial impingement syndrome, confirmed by clinical examination and imaging (such as X-ray or MRI)
* Moderate to severe shoulder pain, with a score of at least 4 on a 0-10 visual analog scale (VAS) for pain
* Willingness to comply with the study protocol and attend all study visits and assessments
* Ability to provide informed consent to participate in the study.
Exclusion Criteria
* Previous shoulder surgery on the affected shoulder
* Other active shoulder conditions, such as rotator cuff tear or adhesive capsulitis, that may confound the study results
* Systemic conditions, such as rheumatoid arthritis or osteoarthritis, that may affect the shoulder joint and its function
* History of shoulder dislocation or instability
* Pregnancy or breastfeeding
* Current use of systemic corticosteroids or immunosuppressive drugs
* Injection to shoulder area in the past six months.
* Inability to complete the study assessments or follow the study protocol, such as due to cognitive impairment or language barrier.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uskudar State Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mustafa Hüseyin Temel
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mustafa H Temel, M.D.
Role: PRINCIPAL_INVESTIGATOR
Uskudar State Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ImpDn1
Identifier Type: -
Identifier Source: org_study_id